Amphetamine (AMPH) abuse constitutes a significant public health issue with important economic and social ramifications. Treatments are hampered by a lack of knowledge of how AMPH works at the molecular level. The long-term objective of this project is to obtain an understanding of the acute pharmacological modulation of the human dopamine transporter (hDAT) activity by AMPH. Dopamine transporters (DATs) that largely control dopamine (DA) clearance are targets for psychostimulants such as cocaine and AMPH. By acting on the DAT, AMPH attenuates the DAT clearance efficiency. As a consequence, AMPH increases synaptic DA levels and enhances dopaminergic transmission with profound effects on behavior. There has been very little study of the effects of AMPH on DATs at the molecular level. This project will combine molecular biology, biochemistry, confocal microscopy and biophysics to elucidate the mechanisms involved in the acute pharmacological regulation of hDAT function by AMPH. The key issues to resolve include how AMPH causes massive release of DA via bDAT, and how AMPH causes hDAT cell surface redistribution, a novel mechanism recently uncovered by us. Both these processes affect the hDAT-mediated DA reuptake, ultimately increasing the extracellular DA concentration. The experimental plan links mechanistic aspects of the transporter function to the pharmacological properties of AMPH, namely AMPH-induced hDAT currents to AMPH-stimulated DA efflux and AMPH-induced hDAT cell surface redistribution. The proposed studies address the following specific aims: 1) to characterizethe ion, voltage and substrate regulation of the AMPH-induced hDAT currents; 2) to determine the relationship between AMPH-induced hDAT current and AMPH-stimulated DA efflux; and 3) to identify the cellular components involved AMPH-induced trafficking of the hDAT. This proposal seeks to identify molecular mechanisms of the AMPH action and to reveal new cellular targets for substance abuse therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA013975-06
Application #
6876480
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Pilotte, Nancy S
Project Start
2001-04-01
Project End
2006-08-14
Budget Start
2005-04-01
Budget End
2006-08-14
Support Year
6
Fiscal Year
2005
Total Cost
$264,250
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Buchmayer, Florian; Schicker, Klaus; Steinkellner, Thomas et al. (2013) Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc Natl Acad Sci U S A 110:11642-7
Hamilton, P J; Campbell, N G; Sharma, S et al. (2013) Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene. Mol Psychiatry 18:1235
Hamilton, P J; Campbell, N G; Sharma, S et al. (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315-23
Graham, D L; Erreger, K; Galli, A et al. (2012) GLP-1 analog attenuates cocaine reward. Mol Psychiatry :
Sakrikar, Dhananjay; Mazei-Robison, Michelle S; Mergy, Marc A et al. (2012) Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci 32:5385-97
Cremona, M Laura; Matthies, Heinrich J G; Pau, Kelvin et al. (2011) Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. Nat Neurosci 14:469-77
Robertson, Sabrina D; Matthies, Heinrich J G; Owens, W Anthony et al. (2010) Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 30:11305-16
Carvelli, Lucia; Matthies, Dawn S; Galli, Aurelio (2010) Molecular mechanisms of amphetamine actions in Caenorhabditis elegans. Mol Pharmacol 78:151-6
Bowton, Erica; Saunders, Christine; Erreger, Kevin et al. (2010) Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci 30:6048-57
Matthies, Heinrich J G; Moore, Jessica L; Saunders, Christine et al. (2010) Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking. J Neurosci 30:7863-77

Showing the most recent 10 out of 30 publications